Study guide

4.1 Protein Chemistry, Amino Acid Metabolism, and Nitrogen Balance

Nutritionist-Dietitian Licensure Examination NDLE

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Licensure Law, Ethics, and the Clinical Nutritionist-Dietitian

1.1 NDLE Format, Scoring Rules, and RA 10862 Licensure Requirements 1.2 Scope of Practice, Professional Ethics, and Discipline under RA 10862 1.3 Role of the Clinical Nutritionist-Dietitian, Diet Orders, and Standard Hospital Diets

2 Chapter 2: Anatomy and Physiology for Nutrition I

2.1 Cells, Tissues, Membranes, and the Immune and Lymphatic Systems 2.2 The Digestive System: Organs, Enzymes, GI Hormones, and the Liver 2.3 Endocrine and Nervous System Regulation of Metabolism and Appetite

3 Chapter 3: Anatomy and Physiology II, Energy, and Carbohydrate Metabolism

3.1 Cardiovascular, Respiratory, Renal, Musculoskeletal, and Reproductive Systems 3.2 Energy Metabolism and Energy Expenditure Calculations 3.3 Carbohydrate Chemistry, Digestion, and Glycemic Pathways

4 Chapter 4: Protein, Lipid, Mineral, and Fluid Biochemistry

4.1 Protein Chemistry, Amino Acid Metabolism, and Nitrogen Balance 4.2 Lipid Metabolism, Lipoproteins, and Cardiovascular Biomarkers 4.3 Minerals, Water, Electrolytes, and Acid-Base Balance

5 Chapter 5: Basic Nutrition: Vitamins, Minerals, and the PDRI

5.1 Vitamin Biochemistry: Coenzyme Functions and Deficiency Syndromes 5.2 Vitamins and Minerals: PDRI Values, Food Sources, Bioavailability, Stability, and Toxicity 5.3 Philippine Dietary Reference Intakes (PDRI 2015), Pinggang Pinoy, and Dietary Guidelines

6 Chapter 6: Diet Computation and Clinical Nutrition Assessment

6.1 Food Exchange Lists, Meal Plan Computation, Food Labels, and Nutrient Density 6.2 Computing Desirable Body Weight, Total Energy Requirement, and the Diet Prescription 6.3 ABCD Methods of Clinical Nutrition Assessment

7 Chapter 7: Nutrition Diagnosis, Life-Stage Assessment, and Laboratory Data

7.1 Nutrition Diagnosis, PES Statements, and Medical Record Documentation 7.2 Pediatric, Obstetric, and Geriatric Clinical Nutritional Assessment 7.3 Interpreting Biochemical and Laboratory Data in Nutrition Assessment

8 Chapter 8: Drug-Nutrient Interactions, Diabetes, and Weight Disorders

8.1 Drug-Nutrient Interactions and Nutrient Depletion 8.2 MNT for Diabetes Mellitus and Endocrine Disorders 8.3 MNT for Overweight, Obesity, and Underweight

9 Chapter 9: MNT for Cardiovascular, Renal, and Gastrointestinal Disease

9.1 MNT for Cardiovascular Disease, Hypertension, and Dyslipidemia 9.2 MNT for Renal Diseases (AKI, CKD Stages 1-5, Dialysis, and Nephrotic Syndrome) 9.3 MNT for Disorders of the Gastrointestinal Tract

10 Chapter 10: MNT for Liver, Infectious, Respiratory, Allergic, and Neurologic Conditions

10.1 MNT for Liver, Gallbladder, and Pancreatic Disorders 10.2 MNT for Fevers, Infections, Diarrheal Disease, and Respiratory Disorders 10.3 MNT for Food Allergy and Intolerance, Skin, Rheumatic, Musculoskeletal, and Neurologic Disorders

11 Chapter 11: Critical Illness, Oncology, HIV, and Protein-Energy Malnutrition

11.1 MNT in Critical Illness, Sepsis, Trauma, and Burns 11.2 MNT in Oncology: Cancer Cachexia and Treatment Side Effects 11.3 MNT for HIV/AIDS and for Protein-Energy Malnutrition in Children and Adults

12 Chapter 12: Metabolic Disorders, Dysphagia, and Enteral Nutrition

12.1 MNT for Inborn Errors of Metabolism and Eating Disorders 12.2 Dysphagia, IDDSI Texture-Modified Diets, and Adaptive Feeding 12.3 Enteral Nutrition: Indications, Formula Selection, Access Routes, and Complications

13 Chapter 13: Parenteral Nutrition, Refeeding, and Nutrition Counseling

13.1 Parenteral Nutrition: Indications, Access, Substrates, and Compounding 13.2 Refeeding Syndrome and Complications of Parenteral Nutrition 13.3 Nutrition Counseling and Behavior Change Theories

14 Chapter 14: Nutrition Updates: Supplements, Diet Trends, and Sports Nutrition

14.1 Dietary Supplements, Herbal Medicines, and Functional Foods 14.2 Vegetarian Diets, Protein Complementation, and Popular Diet Trends 14.3 Sports Nutrition and Workplace Wellness Programs

15 Chapter 15: Community Nutrition and Population Assessment

15.1 Community Nutrition Principles, the ND's Roles, and the Philippine Health Delivery System 15.2 Nutritional Epidemiology and Health Status Indicators in the Philippines 15.3 Assessment of Community Nutritional Status and Operation Timbang Plus (OPT+)

16 Chapter 16: Dietary Surveys, Nutrition Research, and Surveillance

16.1 Food Consumption Surveys, Biochemical Tests in Surveys, and Clinical Signs of Deficiency 16.2 Food and Nutrition Research Methods, Sampling, Sample Size, and Research Ethics 16.3 National Nutrition Surveys, Demographic Data, and Designing a Nutrition Surveillance System

17 Chapter 17: Nutrition Education and Program Evaluation

17.1 Nutrition Education: Definition, Principles of Learning, Methods, and Teaching Aids 17.2 Designing a Nutrition Education Program and Measuring Customer Satisfaction 17.3 Program Planning Cycle, SMART Objectives, and Types of Evaluation

18 Chapter 18: Program Planning, Interventions, and Food Security

18.1 Nutrition Program Planning: Needs, Priorities, Constraints, Goals, and Using Evaluation Results 18.2 Nutrition Interventions and Programs for Specific Population Groups 18.3 Food and Nutrition Security, Dietary Diversity, and Vulnerable Populations

19 Chapter 19: Nutrition Governance, Networking, and Program History

19.1 National Nutrition Council (NNC) Structure and Philippine Plan of Action for Nutrition (PPAN) 19.2 Nutrition Agencies, Networking, Community Linkages, Teamwork, and Nutrition Legislation 19.3 Development of Philippine Nutrition Programs and the Country's Nutrition Problems

20 Chapter 20: Fortification, Feeding, and First 1,000 Days Laws

20.1 Food Fortification (RA 8976), Salt Iodization (RA 8172), and the 2024 Salt Industry Law 20.2 Supplementary Feeding Programs (RA 11037) and DSWD/DepEd Interventions 20.3 First 1,000 Days Law (RA 11148) and Maternal-Child Interventions

21 Chapter 21: Nutrition in the Life Cycle I

21.1 Infant and Young Child Feeding (IYCF), Philippine Milk Code (EO 51), and RA 10028 21.2 Nutrition in Pregnancy and Lactation: Physiology, Needs, Meal Patterns, and Problems 21.3 Nutrition from Infancy to School Age: Growth, Feeding Patterns, Problems, and School Programs

22 Chapter 22: Nutrition in the Life Cycle II

22.1 Nutrition for Adolescents and Adults: Growth Spurt, Risk Factors, and NCD Prevention 22.2 Nutrition for Older Adults: Aging Changes, Needs, Problems, and Senior Citizen Programs

23 Chapter 23: Food Science and Plant Foods

23.1 Chemistry of Starches, Proteins, Lipids, and Emulsions in Cooking 23.2 Food Pigments, Flavor Chemistry, and Browning Reactions (Maillard & Enzymatic) 23.3 Fruits, Vegetables, and Legumes: Classification, Market Forms, Quality, Storage, and Cookery

24 Chapter 24: Animal Foods, Cereals and Baking, and Cooking Methods

24.1 Meat, Poultry, Fish, Eggs, and Milk: Structure, Quality, Storage, and Cookery 24.2 Cereals, Flour Mixtures and Baking, Sugar Cookery, Fats and Oils, and Beverages 24.3 Heat Transfer, Dry-Heat and Moist-Heat Cooking Methods, and Filipino Cooking Techniques

25 Chapter 25: Culinary Skills, Family Meal Planning, and Food Quality

25.1 Culinary Vocabulary, Knife Cuts, Basic Sauces, and Accurate Measurement 25.2 Meal Planning for the Family, Food Budgeting, and Recipe Development 25.3 Sensory Evaluation, Objective Food Tests, and Quality Assurance in Food Production

26 Chapter 26: Food Microbiology, Preservation, and Food Law

26.1 Foodborne Pathogens, Microbial Kinetics, and FAT TOM Parameters 26.2 Food Preservation Methods, Thermal Processing, and Packaging 26.3 Philippine Food Laws, Regulatory Agencies, and Food Labeling

27 Chapter 27: Sanitation, HACCP, Waste, and Workplace Safety

27.1 Sanitation Standard Operating Procedures (SSOP) and Good Manufacturing Practices (GMP) 27.2 HACCP Principles and Critical Control Point Management in Food Service 27.3 Waste Management, Pest Control Regulation, and Occupational Safety in Food Service

28 Chapter 28: Food Service Systems, Production Planning, and Menus

28.1 Types of Food Service Delivery Systems (Conventional, Ready-Prepared, Commissary, Assembly) 28.2 Forecasting, Production Planning, and Quantity Food Production Techniques 28.3 Institutional Menu Planning, Modified Diets, and Recipe Standardization

29 Chapter 29: Distribution, Purchasing, and Storage

29.1 Food Distribution and Service Systems in Hospitals and Other Institutions 29.2 Food Purchasing Methods, Specifications, and Receiving 29.3 Storage Management, Inventory Control, and Valuation

30 Chapter 30: Cost Control, Financial Management, and Facility Layout

30.1 Food Cost Accounting, Yield Testing, and Portion Control Formulas 30.2 Menu Pricing Models, Break-Even Analysis, and Financial Statements 30.3 Food Service Facility Layout, Equipment Selection, and Workflow Ergonomics

31 Chapter 31: Equipment, Management, and Human Resources

31.1 Food Service Equipment: Selection, Capacity, Life-Cycle Cost, Depreciation, and Maintenance 31.2 Management Functions, Theories, Leadership Styles, and Managing Change in Food Service 31.3 Human Resource Management: Job Design, Recruitment, Training, Appraisal, and Discipline

32 Chapter 32: Labor Law, Permits, and Food Service Marketing

32.1 Philippine Labor Laws and Business Permits for Food Service Operations 32.2 Food Service Marketing, Menu Engineering, and Sustainable Food Service

4.1 Protein Chemistry, Amino Acid Metabolism, and Nitrogen Balance

Key Takeaways Explain This Topic AI

The nine indispensable amino acids cannot be synthesized endogenously, with branched-chain amino acids (leucine, isoleucine, valine) metabolized primarily in skeletal muscle, where leucine directly stimulates muscle protein synthesis via mTORC1 phosphorylation.

Protein quality metrics have progressed from animal growth models (PER) and fecal balance (PDCAAS) to the Digestible Indispensable Amino Acid Score (DIAAS), which measures true ileal amino acid digestibility without truncation.

Pancreatic zymogen activation in the duodenal lumen is initiated exclusively by enterocyte brush border enteropeptidase (enterokinase), which cleaves trypsinogen into active trypsin, triggering a cascade that activates chymotrypsin, elastase, and carboxypeptidases.

Hepatic transamination of amino acids transfers amino groups to α \alpha α -ketoglutarate via PLP-dependent aminotransferases (ALT, AST), channeling nitrogen into mitochondrial glutamate dehydrogenase and the urea cycle for safe excretion.

Nitrogen balance quantifies net whole-body protein turnover using the clinical formula NB = Protein Intake (g) 6.25 − ( UUN + 4 g ) \text{NB} = \frac{\text{Protein Intake (g)}}{6.25} - (\text{UUN} + 4\text{ g}) NB = 6.25 Protein Intake (g) ​ − ( UUN + 4 g ) , where positive values reflect anabolism and negative values identify catabolic lean mass wasting.

Last updated: October 2026

Proteins are linear polymers of L- α \alpha α -amino acids linked by covalent peptide bonds. Accounting for approximately 16% of total body weight in healthy adults, proteins are continuously synthesized, degraded, and remodeled through protein turnover. Unlike carbohydrates and lipids, the human body lacks an inert storage depot for protein; every gram of body protein fulfills an active structural, catalytic, transport, or immunological role. Consequently, uncompensated protein loss directly compromises physiological reserves, immune competence, and wound healing.

Amino Acid Structure and Classification

Each amino acid possesses a central chiral α \alpha α -carbon bonded to four distinct chemical groups: a basic amino group ( − N H 2 -NH_2 − N H 2 ​ ), an acidic carboxyl group ( − C O O H -COOH − COO H ), a hydrogen atom ( − H -H − H ), and a variable side chain ( − R -R − R group) that confers unique chemical properties.

Indispensable, Dispensable, and Conditionally Indispensable Amino Acids

In nutritional science, amino acids are categorized based on the human body's capacity for de novo synthesis:

Indispensable (Essential) Amino Acids (9): Amino acids whose carbon skeletons cannot be synthesized by human metabolic pathways at rates commensurate with physiological needs. They must be supplied preformed in the diet: Histidine, Isoleucine, Leucine, Lysine, Methionine, Phenylalanine, Threonine, Tryptophan, and Valine (mnemonic: PVT TIM HaLL ).

Dispensable (Non-essential) Amino Acids (5): Synthesized endogenously from central metabolic intermediates (pyruvate, oxaloacetate, α \alpha α -ketoglutarate, 3-phosphoglycerate): Alanine, Asparagine, Aspartate, Glutamate, and Serine .

Conditionally Indispensable Amino Acids (6): Normally synthesized endogenously in adequate amounts, but synthesis becomes rate-limiting during periods of severe physiological stress, prematurity, trauma, sepsis, or organ failure:

Arginine: Becomes essential during rapid neonatal growth, severe sepsis, and wound healing; indispensable for nitric oxide synthesis and urea cycle intermediate flow.

Cysteine: Synthesized from methionine; becomes essential in premature neonates or patients with hepatic cirrhosis due to low cystathionine β \beta β -synthase and cystathionase activity.

Glutamine: The primary respiratory fuel for rapidly dividing enterocytes, colonocytes, and lymphocytes. Under catabolic stress (major thermal burns, polytrauma, critical illness), muscular glutamine stores are rapidly exhausted, impairing gut barrier function and systemic immunity unless supplied exogenously.

Glycine: Becomes rate-limiting in severe burn injuries for collagen synthesis and glutathione conjugation.

Proline: Essential during massive tissue rebuilding and wound remodeling for collagen triple-helix hydroxylation.

Tyrosine: Synthesized by the hydroxylation of phenylalanine via phenylalanine hydroxylase (PAH). In patients with Phenylketonuria (PKU) , an inherited deficiency of PAH renders tyrosine strictly indispensable, requiring medical nutrition therapy with phenylalanine-free, tyrosine-supplemented medical foods.

Specialized Functional Amino Acid Groups

Branched-Chain Amino Acids (BCAAs): Leucine, Isoleucine, and Valine. Unlike most amino acids, BCAAs escape extensive first-pass hepatic metabolism because the liver possesses very low activity of mitochondrial branched-chain aminotransferase (BCAT) . Instead, BCAAs pass directly into systemic circulation and are catabolized predominantly in skeletal muscle , heart, and adipose tissue.

Molecular Signaling Role of Leucine: Leucine is not merely a protein substrate; it acts as a direct, potent nutrient secretagogue and molecular trigger that stimulates the mTORC1 (mechanistic target of rapamycin complex 1) kinase signaling cascade via the Sestrin2 sensor. This phosphorylates p70S6 kinase and 4E-BP1, initiating ribosomal translation and stimulating muscle protein synthesis (MPS).

Maple Syrup Urine Disease (MSUD): An autosomal recessive defect in the branched-chain α \alpha α -keto acid dehydrogenase (BCKDH) multi-enzyme complex leads to toxic accumulation of BCAAs and their branched-chain α \alpha α -keto acids, causing severe neurotoxicity, encephalopathy, cerebral edema, and a characteristic maple syrup odor in urine and cerumen.

Aromatic Amino Acids (AAAs): Phenylalanine, Tyrosine, and Tryptophan. Catabolized almost exclusively in the liver. In severe liver cirrhosis or fulminant hepatic failure, hepatic clearance of AAAs is severely impaired, while peripheral hyperinsulinemia promotes muscle uptake of BCAAs. This significantly lowers the Fischer Ratio (the molar ratio of BCAAs to AAAs: [ L e u + I l e + V a l ] [ P h e + T y r + T r p ] \frac{[Leu + Ile + Val]}{[Phe + Tyr + Trp]} [ P h e + T yr + T r p ] [ L e u + I l e + Va l ] ​ ) from a normal value of > 3.0 > 3.0 > 3.0 down to < 1.0 < 1.0 < 1.0 . The excess circulating AAAs cross the blood-brain barrier via the large neutral amino acid transporter 1 (LAT1), flooding the central nervous system and generating false neurotransmitters (octopamine, phenylethanolamine) that displace dopamine and norepinephrine, exacerbating hepatic encephalopathy .

Sulfur-Containing Amino Acids: Methionine and Cysteine . Methionine is converted to S-adenosylmethionine (SAMe), the universal methyl donor for DNA methylation, creatine synthesis, and phosphatidylcholine production, yielding homocysteine. Elevated homocysteine is an independent cardiovascular biomarker regulated by remethylation (requiring Vitamin B 12 B_{12} B 12 ​ and folate) or transsulfuration to cysteine (requiring Vitamin B 6 B_6 B 6 ​ ).

Protein Quality Evaluation

Protein quality reflects the capacity of a dietary protein to satisfy metabolic nitrogen and indispensable amino acid requirements for tissue maintenance, growth, and repair.

Evaluation Metric Mathematical Formula Underlying Principle Primary Limitations

Biological Value (BV) N retained N absorbed × 100 \frac{N_{\text{retained}}}{N_{\text{absorbed}}} \times 100 N absorbed ​ N retained ​ ​ × 100 Measures the percentage of absorbed nitrogen retained in the body Requires nitrogen-free baseline; ignores digestive losses; laboratory rat model

Net Protein Utilization (NPU) N retained N intake × 100 = BV × Digestibility \frac{N_{\text{retained}}}{N_{\text{intake}}} \times 100 = \text{BV} \times \text{Digestibility} N intake ​ N retained ​ ​ × 100 = BV × Digestibility Measures the proportion of total ingested nitrogen that is converted into body tissue Animal-dependent; does not identify specific limiting amino acids

Protein Efficiency Ratio (PER) Weight Gain (g) Protein Ingested (g) \frac{\text{Weight Gain (g)}}{\text{Protein Ingested (g)}} Protein Ingested (g) Weight Gain (g) ​ Evaluates weight gain of growing male rats fed a 10% test protein diet over 28 days Rodent amino acid requirements (high methionine/cysteine for fur) do not match humans

PDCAAS Amino Acid Score × True Fecal Digestibility \text{Amino Acid Score} \times \text{True Fecal Digestibility} Amino Acid Score × True Fecal Digestibility Evaluates limiting amino acid relative to preschool child reference pattern, adjusted for fecal losses Truncated at 1.00 (masks superior protein value); ignores ileal digestion; overestimates poor proteins

DIAAS min ⁡ ( Digestible IAA in 1g test protein IAA in reference pattern (mg) ) × 100 \min\left( \frac{\text{Digestible IAA in 1g test protein}}{\text{IAA in reference pattern (mg)}} \right) \times 100 min ( IAA in reference pattern (mg) Digestible IAA in 1g test protein ​ ) × 100 Measures true ileal digestibility of each indispensable amino acid sampled at terminal ileum Technical difficulty obtaining human ileal digesta; uses pig or human ileostomy models

The Shift from PDCAAS to DIAAS

The Protein Digestibility-Corrected Amino Acid Score (PDCAAS) was adopted by FAO/WHO in 1991. However, PDCAAS suffers from two major physiological flaws:

Fecal vs. Ileal Digestibility: PDCAAS measures protein disappearance over the entire gastrointestinal tract (fecal analysis). Colonic microbiota ferment undigested protein into ammonia and bacterial biomass, falsely elevating apparent digestibility.

Truncation at 1.00: Any protein with an amino acid score exceeding 1.00 is arbitrarily truncated to 1.00 (e.g., whey, casein, egg white, and soy protein isolate all score 1.00). This prevents clinicians from evaluating the superior capacity of high-quality animal proteins to supplement lower-quality plant proteins.

To overcome these deficits, the FAO introduced the Digestible Indispensable Amino Acid Score (DIAAS) in 2013:

Measures individual amino acid digestibility at the terminal ileum before colonic microflora can distort nitrogen balance.

Values are not truncated , allowing scores above 100% (e.g., milk protein concentrate scores 115–130%, whey isolate scores ~125%, soy isolate scores ~90%, pea protein scores ~82%, and cooked polished rice scores ~60%).

Mutual Supplementation (Protein Complementation)

Plant proteins often contain a limiting amino acid —an indispensable amino acid present in the lowest concentration relative to human requirements:

Grains and Cereals (Rice, Wheat, Corn): Limited in Lysine and Threonine, but rich in Methionine and Cysteine.

Legumes and Pulses (Beans, Lentils, Mung Beans / Munggo): Limited in Methionine and Cysteine, but rich in Lysine.

Clinical Application: Combining complementary plant proteins within the same day—such as the classic Filipino dish ginisang munggo at kanin (mung bean soup with rice)—allows the surplus amino acids of one food to compensate for the deficiencies of the other, achieving a high combined biological value without consuming animal products.

  • Protein Digestion, Zymogen Cascades, and Epithelial Absorption Dietary Protein
  • │
  • ▼ [Gastric Phase: HCl (Parietal cells) denatures protein]
  • ▼ [Pepsinogen (Chief cells) cleaved by HCl to Pepsin]
  • Large Polypeptides & Oligopeptides
  • │
  • ▼ [Duodenal Phase: Chyme stimulates Secretin & CCK]
  • Duodenal Mucosal Enteropeptidase (Enterokinase)
  • │
  • ▼ [Cleaves Trypsinogen to Trypsin]
  • Active Pancreatic Trypsin
  • │
  • ┌─────────────────────┼─────────────────────┐
  • ▼ ▼ ▼
  • Chymotrypsinogen Proelastase Procarboxypeptidases A & B
  • │ │ │
  • ▼ ▼ ▼
  • Chymotrypsin Elastase Carboxypeptidases A & B
  • │ │ │
  • └─────────────────────┼─────────────────────┘
  • │
  • ▼
  • Small Peptides & Free Amino Acids
  • │
  • ┌─────────────────┴─────────────────┐
  • ▼ ▼
  • [PEPT1: H+-Dependent Symport] [Na+-Dependent AA Transporters]
  • Di- and Tripeptides Free Amino Acids
  • │ │
  • ▼ [Cytosolic Peptidases] │
  • └─────────────────┬─────────────────┘
  • │
  • ▼
  • Free Amino Acids in Enterocyte
  • │
  • ▼ [Basolateral Transporters: Facilitated Diffusion]
  • Portal Venous Blood
  • Gastric Phase of Digestion

Hydrochloric Acid (HCl): Secreted by gastric parietal cells (stimulated by gastrin, histamine, and acetylcholine). Gastric acid lowers intraluminal pH to 1.5–2.5, denaturing the tertiary and quaternary structures of globular proteins and uncoiling polypeptide chains to expose peptide bonds.

Pepsin Activation: Chief cells secrete the inactive zymogen pepsinogen . Below pH 3.0, auto-activation cleaves an N-terminal peptide, releasing active pepsin , an endopeptidase that hydrolyzes peptide bonds involving hydrophobic and aromatic amino acids (phenylalanine, tyrosine, tryptophan, leucine).

Pancreatic Phase and the Enterokinase Master Switch

Upon entering the duodenum, acidic chyme stimulates mucosal S-cells to secrete secretin (triggering pancreatic bicarbonate release to neutralize acid) and I-cells to secrete cholecystokinin (CCK) (triggering pancreatic acinar enzyme secretion):

Enteropeptidase (Enterokinase): An integral brush border enzyme synthesized by duodenal mucosal cells. Enterokinase recognizes a specific Asp-Asp-Asp-Asp-Lys sequence on the inactive zymogen trypsinogen , cleaving an N-terminal hexapeptide to generate active trypsin .

Trypsin Auto-Amplification Cascade: Active trypsin serves as the physiological "master key" that autocatalytically activates remaining trypsinogen and cleaves other pancreatic zymogens:

Chymotrypsinogen → \to → Chymotrypsin (endopeptidase cleaving bonds at carboxyl ends of aromatic amino acids).

Proelastase → \to → Elastase (endopeptidase cleaving bonds adjacent to small aliphatic residues like alanine, glycine, serine).

Procarboxypeptidases A and B → \to → Carboxypeptidases A and B (zinc-dependent exopeptidases cleaving single amino acids from the C-terminus).

Enterocyte Absorption: The PEPT1 Advantage

Proteolytic digestion yields approximately 70% small oligopeptides (di- and tripeptides) and 30% free amino acids:

PEPT1 (Peptide Transporter 1): Located on the apical enterocyte membrane, PEPT1 transports dipeptides and tripeptides via an electrogenic H + H^+ H + -coupled symport mechanism, driven by an apical proton gradient generated by the N a + / H + Na^+/H^+ N a + / H + exchanger (NHE3). Small peptides are absorbed substantially faster and with greater kinetic efficiency than an equimolar mixture of free amino acids—a principle utilized in designing semi-elemental peptide-based enteral nutrition formulas for malabsorptive patients.

Once inside the enterocyte cytoplasm, active cytosolic peptidases rapidly hydrolyze di- and tripeptides into free amino acids.

Free amino acids exit the basolateral membrane via sodium-independent facilitated diffusion transporters (such as LAT1, System L, and System y+L) into the portal circulation heading directly to the liver.

Transamination, Deamination, and the Urea Cycle

Amino acid catabolism requires the separation of the α \alpha α -amino group from the carbon skeleton. The carbon skeletons enter the citric acid cycle as glucogenic intermediates (pyruvate, α \alpha α -ketoglutarate, succinyl-CoA, fumarate, oxaloacetate) or ketogenic precursors (acetoacetyl-CoA, acetyl-CoA). The removed nitrogen must be safely detoxified.

Transamination

Transamination is the reversible transfer of an α \alpha α -amino group from an amino acid to an α \alpha α -keto acid (most commonly α \alpha α -ketoglutarate), generating the corresponding α \alpha α -keto acid of the original amino acid and L-glutamate .

Cofactor: All aminotransferases (transaminases) require pyridoxal-5'-phosphate (PLP) , the active coenzyme form of Vitamin B 6 B_6 B 6 ​ .

Clinical Biomarkers:

Alanine Aminotransferase (ALT / SGPT): Alanine + α -Ketoglutarate ⇌ Pyruvate + Glutamate \text{Alanine} + \alpha\text{-Ketoglutarate} \rightleftharpoons \text{Pyruvate} + \text{Glutamate} Alanine + α -Ketoglutarate ⇌ Pyruvate + Glutamate . Predominantly cytosolic and localized primarily in hepatocytes; highly specific biomarker for hepatocellular injury.

Aspartate Aminotransferase (AST / SGOT): Aspartate + α -Ketoglutarate ⇌ Oxaloacetate + Glutamate \text{Aspartate} + \alpha\text{-Ketoglutarate} \rightleftharpoons \text{Oxaloacetate} + \text{Glutamate} Aspartate + α -Ketoglutarate ⇌ Oxaloacetate + Glutamate . Both cytosolic and mitochondrial; found in liver, myocardium, skeletal muscle, and kidneys. An AST:ALT ratio > 2 : 1 > 2:1 > 2 : 1 classically suggests alcoholic liver disease, whereas viral hepatitis typically presents with ALT exceeding AST.

Exceptions: Lysine and threonine do not participate in transamination reactions.

Oxidative Deamination and Ammonia Transport

Glutamate Dehydrogenase (GDH): In mitochondrial matrix of hepatocytes, GDH oxidatively deaminates glutamate to release free, toxic ammonium ion ( N H 4 + NH_4^+ N H 4 + ​ ) and regenerate α \alpha α -ketoglutarate, utilizing N A D + NAD^+ N A D + or N A D P + NADP^+ N A D P + .

Peripheral Ammonia Transport: Extrahepatic tissues cannot synthesize urea. Muscle converts excess amino groups to alanine via the glucose-alanine cycle , which is exported to the liver. Brain and peripheral tissues fix toxic ammonia into glutamate via glutamine synthetase to form non-toxic L-glutamine , which travels through the blood to the liver (where glutaminase releases ammonia for urea synthesis) and kidneys (where glutaminase releases N H 4 + NH_4^+ N H 4 + ​ into urine to buffer metabolic acids).

The Urea Cycle (Krebs-Henseleit Cycle)

The urea cycle is the exclusive mammalian metabolic pathway for converting neurotoxic ammonia into non-toxic, water-soluble urea for renal clearance. It occurs exclusively in hepatocytes, partitioned across two cellular compartments: [MITOCHONDRIAL MATRIX]

  • NH4+ + HCO3- + 2 ATP
  • │
  • ▼ ◄─── N-Acetylglutamate (NAG) [Obligate Allosteric Activator]
  • [1. Carbamoyl Phosphate Synthetase I (CPS-1)] (Rate-Limiting Step)
  • │
  • Carbamoyl Phosphate
  • │
  • ├──────── Ornithine (transported into mitochondria)
  • ▼
  • [2. Ornithine Transcarbamylase (OTC)]
  • │
  • Citrulline
  • │
  • ▼ (Citrulline exported to cytosol via SLC25A15)
  • ─────────────────────────────────────────────────────────────────────────────
  • [CYTOSOL]
  • Citrulline + Aspartate + ATP (Provides second nitrogen)
  • │
  • ▼
  • [3. Argininosuccinate Synthetase (ASS)]
  • │
  • Argininosuccinate
  • │
  • ├──────── Fumarate ──► (Enters Krebs Cycle: "Krebs Bicycle")
  • ▼
  • [4. Argininosuccinate Lyase (ASL)]
  • │
  • L-Arginine + H2O
  • │
  • ▼
  • [5. Arginase-1 (ARG1)]
  • │
  • ├──────── UREA (diffuses to blood ──► excreted in urine)
  • ▼
  • Ornithine (transported back into mitochondria)

Carbamoyl Phosphate Synthetase I (CPS-1): Located in the mitochondrial matrix; catalyzes the condensation of N H 4 + NH_4^+ N H 4 + ​ , H C O 3 − HCO_3^- H C O 3 − ​ , and 2 ATP to form carbamoyl phosphate. This is the rate-limiting step of the urea cycle. CPS-1 is inactive unless allosterically bound by N-acetylglutamate (NAG) . NAG is synthesized from glutamate and acetyl-CoA by NAG synthase, an enzyme allosterically stimulated by arginine .

Ornithine Transcarbamylase (OTC): Mitochondrial; transfers a carbamoyl group from carbamoyl phosphate to ornithine, generating citrulline . OTC deficiency is the most common inherited urea cycle disorder, inherited as an X-linked recessive trait, leading to severe hyperammonemia, respiratory alkalosis, and orotic aciduria.

Argininosuccinate Synthetase (ASS): Cytosolic; condenses citrulline with aspartate (consuming 2 ATP equivalents, forming AMP and P P i PP_i P P i ​ ). This step incorporates the second nitrogen atom of the urea molecule.

Argininosuccinate Lyase (ASL): Cytosolic; cleaves argininosuccinate into L-arginine and fumarate . Fumarate enters the citric acid cycle, linking both cycles in the "Krebs bicycle."

Arginase-1 (ARG1): Cytosolic; hydrolyzes arginine to form urea and regenerate ornithine . Ornithine is shuttled back into the mitochondria via the ORNT1 transporter to initiate another round of the cycle.

Nitrogen Balance Assessment in Clinical Dietetics

Nitrogen balance ( N B NB NB ) is the gold standard clinical method for evaluating the adequacy of dietary protein intake and determining whole-body catabolic versus anabolic status in hospitalized, critically ill, and outpatient populations.

The Nitrogen Factor and Biological Basis

On average, dietary proteins contain 16% nitrogen by weight ( 100 g protein / 16 g nitrogen = 6.25 100\text{ g protein} / 16\text{ g nitrogen} = 6.25 100 g protein /16 g nitrogen = 6.25 ). Thus, dividing protein intake in grams by 6.25 yields total nitrogen intake:

Nitrogen Intake (g) = Protein Intake (g) 6.25 \text{Nitrogen Intake (g)} = \frac{\text{Protein Intake (g)}}{6.25} Nitrogen Intake (g) = 6.25 Protein Intake (g) ​

Clinical Nitrogen Balance Formula

Nitrogen output is determined by analyzing a 24-hour urine collection for Urinary Urea Nitrogen (UUN) , adding a standard correction factor of 4 grams to account for non-urea urinary nitrogen losses and insensible losses:

NB (g/day) = Nitrogen Intake − Nitrogen Output \text{NB (g/day)} = \text{Nitrogen Intake} - \text{Nitrogen Output} NB (g/day) = Nitrogen Intake − Nitrogen Output NB = Protein Intake (g) 6.25 − ( UUN (g/day) + 4 g ) \text{NB} = \frac{\text{Protein Intake (g)}}{6.25} - \left( \text{UUN (g/day)} + 4\text{ g} \right) NB = 6.25 Protein Intake (g) ​ − ( UUN (g/day) + 4 g )

Where the + 4 g +4\text{ g} + 4 g constant comprises:

2 g 2\text{ g} 2 g : Non-urea urinary nitrogen losses (creatinine, uric acid, free amino acids, ammonium ions).

2 g 2\text{ g} 2 g : Fecal nitrogen and insensible integumentary losses (desquamated skin cells, sweat, shed hair, and nails).

Warning

The standard + 4 g +4\text{ g} + 4 g correction factor underestimates nitrogen loss in patients with open abdominal wounds, extensive thermal burns, high-output enterocutaneous fistulas, or continuous renal replacement therapy (CRRT) . In burn injuries, an additional 0.1 to 0.2 g nitrogen/kg/day must be added based on percentage total body surface area burned.

Clinical Interpretation of Nitrogen Balance States

Equilibrium ( NB ≈ 0 g/day \text{NB} \approx 0\text{ g/day} NB ≈ 0 g/day , typically − 1 to + 1 g -1\text{ to }+1\text{ g} − 1 to + 1 g ): Reflects homeostatic maintenance in healthy adults, where protein synthesis equals protein breakdown.

Positive Nitrogen Balance ( NB > + 2 g/day \text{NB} > +2\text{ g/day} NB > + 2 g/day ): Nitrogen intake exceeds nitrogen excretion, indicating net protein accretion and tissue anabolism. Observed in normal infant and childhood growth, pregnancy, lactation, athletic muscle hypertrophy, and recovery/repletion from illness or starvation.

Negative Nitrogen Balance ( NB < − 2 g/day \text{NB} < -2\text{ g/day} NB < − 2 g/day ): Nitrogen excretion exceeds intake, indicating net lean tissue breakdown and muscle wasting. Observed in critical illness, severe thermal burns, polytrauma, untreated sepsis, prolonged starvation, uncontrolled Cushing's syndrome, and cancer cachexia.

Step-by-Step Clinical Calculation Scenario

A 45-year-old male polytrauma patient weighing 70 kg in the surgical intensive care unit receives a specialized enteral nutrition formulation providing 90 grams of intact protein over a 24-hour period. A concurrent 24-hour urine collection reveals a Urinary Urea Nitrogen (UUN) excretion of 14.4 grams . Calculate the patient's nitrogen balance and interpret the clinical result:

Calculate Nitrogen Intake: Nitrogen Intake = 90 g protein 6.25 = 14.40 g N \text{Nitrogen Intake} = \frac{90\text{ g protein}}{6.25} = 14.40\text{ g N} Nitrogen Intake = 6.25 90 g protein ​ = 14.40 g N

Calculate Total Nitrogen Output: Nitrogen Output = UUN + 4 = 14.40 g + 4.0 g = 18.40 g N \text{Nitrogen Output} = \text{UUN} + 4 = 14.40\text{ g} + 4.0\text{ g} = 18.40\text{ g N} Nitrogen Output = UUN + 4 = 14.40 g + 4.0 g = 18.40 g N

Calculate Nitrogen Balance: NB = 14.40 g − 18.40 g = − 4.00 g N/day \text{NB} = 14.40\text{ g} - 18.40\text{ g} = -4.00\text{ g N/day} NB = 14.40 g − 18.40 g = − 4.00 g N/day

Clinical Interpretation: The patient is in a marked negative nitrogen balance ( − 4.0 g N/day -4.0\text{ g N/day} − 4.0 g N/day ), representing a net daily loss of approximately 4.0 × 6.25 = 25 grams of functional body protein 4.0 \times 6.25 = 25\text{ grams of functional body protein} 4.0 × 6.25 = 25 grams of functional body protein , or roughly 100 – 125 grams of wet muscle tissue 100–125\text{ grams of wet muscle tissue} 100–125 grams of wet muscle tissue per day. The clinical dietitian must uptitrate protein delivery (e.g., targeting 1.5–2.0 g/kg/day, or 105–140 g protein) alongside adequate non-protein calories to suppress gluconeogenic muscle proteolysis.